Dupuytren Contracture Clinical Trial
Official title:
Randomized Controlled Trial Comparing the Effectiveness of Two Post-fasciectomy Rehabilitation Protocols Differing in Intensity and Implementation of Modalities in Patients With Dupuytren's Disease
Verified date | June 2019 |
Source | Laval University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Dupuytren's disease can cause physical impairments that lead to reduced functional
performance in personal care, work-related and leisure activities. The prevalence of
Dupuytren's disease increases with age. A meta-analysis completed in 2014 by Lanting and al.
estimated the its prevalence in western countries at 12% among people aged 55 years and over
and at 29% among individuals aged 75 and over. The fasciectomy is the most current surgical
procedure to reduce the flexion contracture occurring in this disease. Studies confirm the
relevance of post-operative rehabilitation after fasciectomy. This rehabilitation is usually
conducted by hand therapists who are mostly occupational therapists. However, the required
duration and frequency of interventions and exercises for the post-op rehabilitation are not
clearly described in the literature. In fact, the guidelines that are currently available
recommend a total duration between 16 and 75 hours, which is highly variable. Also, the need
to include supervised exercises by the occupational therapist is not specified. The main goal
of this study is to compare two post-fasciectomy rehabilitation protocols to determine the
influence of protocols intensity on motor and functional outcomes in people with Dupuytren's
disease. The hypothesis is that the protocol involving a higher intensity will lead to better
motor and functional improvements. The secondary goal of this study is to explore the link
between the total time that the person has done the recommended exercises (combination of
supervised exercises and the home program) and motor/functional recovery. The hypothesis is
that the relationship between the amount of time and the motor/functional improvements will
not be linear, but will either be logarithmic toward a plateau of recovery.
A randomized controlled trial will be realized. 40 participants will be randomly assigned to
one of the two rehabilitation protocols. Each participant will be evaluated at four times
(initial evaluation, final evaluation and 2 follow-up evaluations). Data on motor and
functional recovery will be collected.
Status | Enrolling by invitation |
Enrollment | 40 |
Est. completion date | December 2020 |
Est. primary completion date | December 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 55 Years to 75 Years |
Eligibility |
Inclusion Criteria: - To present Dupuytren's contracture to one or two digits of the same hand and at an important stage of Dupuytren's Disease before the surgery (PIP contracture of 45 degrees or more) - Having had a fasciectomy to treat Dupuytren's Disease with per-op PIP contracture of 30 degrees or less. Exclusion Criteria: - Recurrence of Dupuytren's Disease - To have or have had a complex regional pain syndrome - To present a health condition that could affect cognitive functions (dementia, neuro-cognitive disorders) - To have a diagnosis of diabetes |
Country | Name | City | State |
---|---|---|---|
Canada | CHU de Québec | Québec |
Lead Sponsor | Collaborator |
---|---|
Véronique Flamand | Centre interdisciplinaire de recherche en réadaptation et intégration sociale, CHU de Quebec-Universite Laval |
Canada,
Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice. BMC Musculoskelet Disord. 2013 Apr 10;14:131. doi: 10.1186/1471-2474-14-131. Review. — View Citation
Bayat A, McGrouther DA. Management of Dupuytren's disease--clear advice for an elusive condition. Ann R Coll Surg Engl. 2006 Jan;88(1):3-8. Review. — View Citation
Bell-Krotoski JA, Fess EE, Figarola JH, Hiltz D. Threshold detection and Semmes-Weinstein monofilaments. J Hand Ther. 1995 Apr-Jun;8(2):155-62. — View Citation
Budd HR, Larson D, Chojnowski A, Shepstone L. The QuickDASH score: a patient-reported outcome measure for Dupuytren's surgery. J Hand Ther. 2011 Jan-Mar;24(1):15-20; quiz 21. doi: 10.1016/j.jht.2010.08.006. Epub 2010 Nov 24. — View Citation
Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am. 2011 May;36(5):936-42. doi: 10.1016/j.jhsa.2011.03.002. Review. — View Citation
Efanov JI, Shine JJ, Darwich R, Besner Morin C, Arsenault J, Harris PG, Danino AM, Izadpanah A. French translation and cross-cultural adaptation of the Michigan Hand Outcomes Questionnaire and the Brief Michigan Hand Outcomes Questionnaire. Hand Surg Rehabil. 2018 Apr;37(2):86-90. doi: 10.1016/j.hansur.2017.12.003. Epub 2018 Jan 17. — View Citation
Huisstede BM, Hoogvliet P, Coert JH, Fridén J; European HANDGUIDE Group. Dupuytren disease: European hand surgeons, hand therapists, and physical medicine and rehabilitation physicians agree on a multidisciplinary treatment guideline: results from the HANDGUIDE study. Plast Reconstr Surg. 2013 Dec;132(6):964e-76e. doi: 10.1097/01.prs.0000434410.40217.23. — View Citation
Huskisson EC. Measurement of pain. Lancet. 1974 Nov 9;2(7889):1127-31. — View Citation
Lanting R, Broekstra DC, Werker PM, van den Heuvel ER. A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of Western countries. Plast Reconstr Surg. 2014 Mar;133(3):593-603. doi: 10.1097/01.prs.0000438455.37604.0f. Review. Erratum in: Plast Reconstr Surg. 2014 May;133(5):1312. — View Citation
Lewis E, Fors L, Tharion WJ. Interrater and intrarater reliability of finger goniometric measurements. Am J Occup Ther. 2010 Jul-Aug;64(4):555-61. — View Citation
Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am. 1984 Mar;9(2):222-6. — View Citation
Melchior H, Vatine JJ, Weiss PL. Is there a relationship between light touch-pressure sensation and functional hand ability? Disabil Rehabil. 2007 Apr 15;29(7):567-75. — View Citation
Sollerman C, Ejeskär A. Sollerman hand function test. A standardised method and its use in tetraplegic patients. Scand J Plast Reconstr Surg Hand Surg. 1995 Jun;29(2):167-76. — View Citation
Sweet S, Blackmore S. Surgical and therapy update on the management of Dupuytren's disease. J Hand Ther. 2014 Apr-Jun;27(2):77-83; quiz 84. doi: 10.1016/j.jht.2013.10.006. Epub 2013 Nov 5. Review. — View Citation
Wilburn J, McKenna SP, Perry-Hinsley D, Bayat A. The impact of Dupuytren disease on patient activity and quality of life. J Hand Surg Am. 2013 Jun;38(6):1209-14. doi: 10.1016/j.jhsa.2013.03.036. — View Citation
* Note: There are 15 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from first evaluation on the Michigan Hand Questionnaire at 2, 3 and 6 months | Patient-reported questionnaire that evaluates function and quality of life in patients with hand disorders. There are 37 items divided into 6 subscales (1)overall hand function, (2)activities of daily living, (3)pain, (4)work performance, (5)aesthetics and (6)patient's satisfaction with hand function). (Total score between 0-100, rating scale from 1 to 5) | 0-3 days, 2 months, 3 months and 6 months after surgery | |
Primary | Change from first evaluation on the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) outcome measure at 2, 3 and 6 months | Patient-reported questionnaire that evaluates 11 items on symptoms and functional impairments related to musculoskeletal disorders of the upper limb. (Total score between 0-100, rating scale from 1 to 5) | 0-3 days, 2 months, 3 months and 6 months after surgery | |
Primary | Change from first evaluation on the Sollerman Test at 2, 3 and 6 months | A standardized hand function assessment based on seven of the eight most common hand grips that consists of 20 activities of daily living. (Total score between 0-80, rating scale 0 to 4). | 2 months and 6 months after surgery | |
Secondary | Range of motion assessed by Rolyan digital goniometer | Range of motion of the affected digits assessed by Rolyan digital goniometer (data scope -30° to 120°, accuracy of 2°) | 0-3 days, 2 months, 3 months and 6 months after surgery | |
Secondary | Pain measured using the Visual Analogue Scale | Responders specify their level of pain by indicating a position along a continuous line between two end-points. One end (corresponding to score 0) represents the absence of pain, and the other end (corresponding to score 100) represents the worst pain that the person can imagine. (Thus the minimum score is 0, and the maximum score is 100. There are no sub-scales. 0 represents the absence of pain, and higher values represent more pain.) | 0-3 days, 2 months, 3 months and 6 months after surgery | |
Secondary | Grip strength | JAMAR dynamometer (data scope 0-80 kg, accuracy of 2 kg) | 2 months, 3 months and 6 months after surgery | |
Secondary | Pinch strength | B&L pinch gauge (data scope 0-30 pounds, accuracy of 1 pound) | 2 months, 3 months and 6 months after surgery | |
Secondary | Tactile sensibility | Semmes-Weinstein monofilaments | 2 months, 3 months and 6 months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03155854 -
The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring
|
N/A | |
Active, not recruiting |
NCT03192020 -
Trial Comparing Treatment Strategies in Dupuytren's Contracture
|
Phase 4 | |
Recruiting |
NCT05300893 -
Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture
|
N/A | |
Completed |
NCT02647619 -
Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF
|
Phase 4 | |
Recruiting |
NCT01184586 -
Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)
|
Phase 2 | |
Recruiting |
NCT04122313 -
Post-contracture Release Radiation for Dupuytren's Disease
|
||
Withdrawn |
NCT01776892 -
Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease
|
Phase 3 | |
Completed |
NCT02983162 -
Is wGRS Associated With DD Recurrence?
|
||
Completed |
NCT01923103 -
Natural Disease Progress of Dupuytren Disease
|
||
Not yet recruiting |
NCT04907812 -
The Role of Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery
|
Phase 4 | |
Withdrawn |
NCT03031080 -
BOND Study: the Benefit Of Night Splinting in Dupuytrens'
|
N/A | |
Completed |
NCT04874870 -
Effectiveness of Splinting After Collagenase Injection
|
Phase 3 | |
Active, not recruiting |
NCT03407820 -
Different Sutures in Hand Surgery
|
N/A | |
Recruiting |
NCT03000114 -
Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease
|
Phase 4 | |
Recruiting |
NCT05440240 -
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
|
Phase 4 | |
Completed |
NCT03331926 -
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
|
||
Active, not recruiting |
NCT03741764 -
Treatment of Dupuytren's Disease With Minimal Invasive Surgery and VIVOSORB® Resorbable Implant Device
|
N/A | |
Completed |
NCT01876498 -
Registry of Patient With M. Dupuytren and Validation of the Brief MHQ
|
N/A | |
Completed |
NCT03868449 -
Question Prompt List for Common Hand Conditions
|
N/A | |
Completed |
NCT03573765 -
Epidemiology and Outcomes of Upper Limb Surgery: Analysis of Routine Data
|